Abdominal Lateral Wall Hematoma Developed Due to Enoxaparin in A Covid-19 Patient
Akademik Acil Tip Olgu Sunumlari Dergisi
; 12(4):100-102, 2021.
Article
in English
| EMBASE | ID: covidwho-1822753
ABSTRACT
A 43-year-old male patient without any additional disease, surgery or anticoagulant use admitted to the emergency department. After evaluation with computed tomography (CT), pulmonary findings were consistent with COVID-19 pneumonia. The patient was hospitalized and enoxaparin sodium 60 mg / 0.6 ml (two subcutaneous injections per day) was initiated for prophylactic purpose. In the 16th day after admission, his hemoglobin level decreased to 7.4 g/dL. On CT scan, a right flank hematoma reaching approximately 10 cm in width, starting from the subcostal level and continuing to the inguinal canal level, was seen. Anticoagulant therapy was stopped. Erythrocyte suspension (ES), totally 10 units, were given to keep the hemoglobin level above 7 g/dL. On the 32th day after admission, the patient was discharged because his hemoglobin value, which was 10.2 g/dL at that point, had not decreased, his vital signs were stable, and his treatment for COVID-19 was completed.
C reactive protein; creatine; creatine kinase; enoxaparin; favipiravir; fibrinogen; hemoglobin; lactate dehydrogenase; moxifloxacin; piperacillin plus tazobactam; abdominal bleeding; abdominal disease; abdominal mass; adult; anticoagulant therapy; article; auscultation; blood pressure; case report; clinical article; computer assisted tomography; coronavirus disease 2019; coughing; drug withdrawal; dyspnea; erythrocyte transfusion; follow up; heart rate; hematoma; hemoglobin blood level; human; inguinal canal; male; wheezing
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Akademik Acil Tip Olgu Sunumlari Dergisi
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS